LyGenesis
PrivateLast Round
Series A
Extension
Oct 24, 2023
Total Funding Raised
$37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
LyGenesis is a clinical-stage biotechnology company developing cell therapies that use a patient's lymph nodes as bioreactors to regrow functioning ectopic organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LyGenesis Comparables
Compare LyGenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellite Bio | 81% | |
| Morphocell Technologies | 80% | |
| HepaTx Corporation | 80% | |
LyGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 24, 2023 | ||||
| Convertible Debt | Dec 30, 2020 | ||||
| Convertible Debt | Oct 21, 2019 | ||||
| Series A | May 9, 2018 |
LyGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevity Vision Fund | Convertible Debt |
| Prime Movers Lab | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 78% MoM.
- Dec 30, 2020
$11M round led by Longevity Vision Fund and Juvenescence
LyGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LyGenesis's valuation, stock price, and market status.